Over-the-counter sale of 14 steroid creams has been banned by the Health Ministry

The Indian health ministry made amendments to certain rules of the Drugs and Cosmetics Rules, 1945 and put 14 steroid-based creams and ointments under the Schedule H category.

This step has been taken to stop the indiscriminate sale of topical preparations containing steroids and antibiotics without the prescription.

Actually, this move is the result from the complaint made by the dermatologists where they clearly mentioned that many of their patients used steroid- based creams and ointments without medical supervision as many of the pharma companies were selling them freely over the counter.

The notice was released by the Health Ministry on this change in the March 2018. Drugs Technical Advisory Board (DTAB) also had submitted their consideration to Central Drugs Standards Control Organisation (CDSCO) regarding the ban on steroid based creams and ointments. Finally, Health Ministry made a decision with the consultation DTAB and CDSCO.

These rules are not applicable for ordinary face-cleansing and moisturizers. Some of the common creams that get banned are alclometasone, beclomethasone, and desonide etc.

Related Posts

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg